XML 59 R42.htm IDEA: XBRL DOCUMENT v3.25.4
Summary of Significant Accounting Policies - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Concentration Risk [Line Items]      
Sales and marketing $ 82,433 $ 71,570 $ 65,055
Research and development 161,621 142,499 136,917
Cost of revenue 361,835 314,672 295,387
Impairment of certain long-lived assets 52 356 1,140
Impairment loss 52 356 1,140
Goodwill 348,674 348,674 348,322
Intangible assets with indefinite lives 46,657 44,822  
Impairment charges for goodwill and indefinite-lived intangible assets 0 0 0
Intangible assets with definite lives 52,847 72,896  
Advertising expense $ 9,651 $ 9,958 7,857
Dividend yield 0.00%    
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000  
Property, Plant and Equipment      
Concentration Risk [Line Items]      
Depreciation period 6 years    
Impairment of certain long-lived assets   $ 815 0
Minimum | JournalDev IT      
Concentration Risk [Line Items]      
Useful life 3 years    
Maximum | JournalDev IT      
Concentration Risk [Line Items]      
Useful life 10 years    
Revision of Prior Period, Adjustment | Reclassification from sales and marketing to cost of revenue      
Concentration Risk [Line Items]      
Sales and marketing     (7,972)
Cost of revenue     7,972
Revision of Prior Period, Adjustment | Reclassification from research and development to cost of revenue      
Concentration Risk [Line Items]      
Research and development     (3,448)
Cost of revenue     $ 3,448